https://wiki.tiffa.net/w/index.php?action=history&feed=atom&title=Translations%3AAnti-obesity_medication%2F18%2Fen 2026-10-06T01:14:03Z Revision history for this page on the wiki MediaWiki 1.43.0 https://wiki.tiffa.net/w/index.php?title=Translations:Anti-obesity_medication/18/en&diff=125274&oldid=prev 2024-03-07T09:16:04Z

<p>Importing a new version from external source</p> <p><b>New page</b></p><div>{| class=&quot;wikitable&quot;<br /> |+<br /> !Medication Name<br /> !Trade name(s)<br /> !Mechanism of action<br /> !Current FDA Status<br /> !placebo-adjusted percent bodyweight lost (highest dose studied)<br /> |-<br /> |[[Lorcaserin]]<br /> |Belviq<br /> |[[5-HT2C receptor]] agonist<br /> |Withdrawn for safety reasons<br /> | 6.25 percent<br /> |-<br /> |[[Sibutramine]]<br /> |Meridia<br /> |[[Serotonin–norepinephrine reuptake inhibitor]]<br /> |Withdrawn due to cardiovascular risks<br /> | 19.7 percent<br /> |-<br /> |[[Rimonabant]]<br /> |Acomplia, Zimbutli<br /> |[[Cannabinoid receptor antagonist]]<br /> |Withdrawn for safety reasons<br /> | {{convert|2.6 to 6.3|kg}}<br /> |-<br /> |[[Fenfluramine]]<br /> |<br /> |[[Serotonin releasing agent]]<br /> |Withdrawn for safety reasons<br /> | -<br /> |-<br /> |[[Fenfluramine/phentermine]] (fen-phen)<br /> |Pondimin<br /> |<br /> |Withdrawn for safety reasons<br /> |13.9 percent<br /> |-<br /> |[[Dexfenfluramine]]<br /> |Redux<br /> |[[Serotonin releasing agent]]<br /> |Withdrawn for safety reasons<br /> |{{convert|3.5|kg}}<br /> |-<br /> |[[2,4-Dinitrophenol]]<br /> |<br /> |[[Uncoupling agent]]<br /> |Withdrawn for safety reasons<br /> |{{convert|17.1|lb}} per patient on average (uncontrolled study)</div>

FuzzyBot